Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.95 USD | +2.86% | +2.60% | -30.82% |
05-07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.82% | 1.13B | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- Piper Sandler Trims Price Target on AbCellera Biologics to $21 From $22, Maintains Overweight Rating